main content start
Januvia (sitagliptin) is a type 2 diabetes oral medication in the DPP-4 inhibitor class of drugs. It lowers blood glucose by slowing the inactivation of GLP-1, a compound in the body that lowers blood glucose levels.
It is approved for adults with type 2 diabetes.
- Janumet is used to improve blood glucose in adults with type 2 diabetes by decreasing glucose production in the liver and absorption of glucose by the intestines, as well as regulating the body's levels of insulin production after eating.
- It is not used to treat type 1 diabetes.
- Janumet should be taken with meals and according to your doctor's instructions.
- Common side effects may include low blood glucose (if you also use insulin or another oral diabetes medication), upset stomach, indigestion, gas, diarrhea, nausea, vomiting, headache, weakness, or cold-like symptoms such as runny or stuffy nose, sneezing, or sore throat.
Januvia Specs
Key specification
Generic Name
Sitagliptin
Drug Class
DPP-4 inhibitors
General Information
Product Name
Januvia
Product Type
Oral Medications
Brand
Merck
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
